Products

Products

Introduction/ Business Area

Types of Biomarker

1

Prognostic biomarker

  • Predict recurrence or progression risks
  • Determination of surgery or alternative treatment
2

Predictive biomarker

  • Predict therapeutic intervention efficacy
  • Determination of specific treatment usage or alternative solution

Precision Medicine Business

Pipeline Drug Development Phase I Phase II Phase III
Biomarker Development Single center Validation Multi-center validation (Global)
PROGNOSTICS HCC OncoHepaTest®
CRC PCRT
HNSCC Prognosis
TNBC Prognosis
HCC TACE
Liver Fibrosis Prognosis of progressiveness
PREDICTIVE HCC Nexavar® (ORR)
HCC Nexavar® (DCR)
TNBC Doxorubicin + Cyclophosphamide
HNSCC First line palliative therapy
SCLC Keytruda + Taxol
PSC IMFINZI + Tremelimumab (Immune therapy)
ACC Axitinib

Biomarker development Business

Pipeline Analysis Platform Platform development Platform validation Commercialization
Prognostic · Predictive · Precision medicine service CbsBio AI platform (STATS, MLBS, PINGS)